EMAIL DETAILS
SUBJECT:
RE: mutual patient
PRI: NORMAL
FROM:
J
jon.glass@jefferson.edu
DATE:
2014-04-15 20:20:03
MSG_ID:
<8e0da894b9b24a5292a69bde68698503@BY2PR05MB742.namprd05.prod.outlook.com>
RECIPIENTS:
TO:
2
261penn@gmail.com
CC:
H
Olivere Hallie
<halliebiden@gmail.com>
H
Hunter Biden
<hbiden@rosemontseneca.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
?I have approval for avastin. Please let me know what day is best for you (we could probably get it done friday of this week). j glass ________________________________ From: 261penn@gmail.com <261penn@gmail.com> Sent: Tuesday, April 15, 2014 12:14 PM To: Jon Glass Cc: Olivere Hallie; Hunter Biden Subject: RE: mutual patient Confidentiality Notice: This electronic message and any attachment(s) are confidential and may be subject to the attorney/client privilege and/or work product immunity. This e-mail is only for the use of the intended recipient(s). If you have received this e-mail in error, please notify the sender immediately by replying to this e-mail, then delete this message and any attachment(s) from your system. Any unintended transmission expressly shall not waive the attorney/client privilege or any other privilege. On Tue, Apr 15, 2014 at 12:06 PM, Jon Glass <Jon.Glass@jefferson.edu<mailto:Jon.Glass@jefferson.edu>> wrote: ??I will need to get this precertified; will expedite. J Glass ________________________________ From: 261penn@gmail.com <261penn@gmail.com> Sent: Tuesday, April 15, 2014 11:34 AM To: Jon Glass Cc: Olivere Hallie; Hunter Biden; Yung,W K Alfred Subject: RE: mutual patient Great. Anytime this week. Just let me know when. Confidentiality Notice: This electronic message and any attachment(s) are confidential and may be subject to the attorney/client privilege and/or work product immunity. This e-mail is only for the use of the intended recipient(s). If you have received this e-mail in error, please notify the sender immediately by replying to this e-mail, then delete this message and any attachment(s) from your system. Any unintended transmission expressly shall not waive the attorney/client privilege or any other privilege. On Tue, Apr 15, 2014 at 10:58 AM, Jon Glass <Jon.Glass@jefferson.edu<mailto:Jon.Glass@jefferson.edu>> wrote: ?Certainly. I will start the process. J Glass ________________________________ From: Yung,W K Alfred <wyung@mdanderson.org> Sent: Tuesday, April 15, 2014 10:08 AM To: Jon Glass Cc: Downey,Ginger Subject: mutual patient Jon, The MRI yesterday showed about the same picture as in March. The nodular enhancement is slight less, but the spectroscopy of the posterior margin showed high choline. I am impressed with the degree of dysphasia he has. I am thinking of giving him 3-4 doses of Avastin to treat the necrosis so we can have a clearer picture of the background ?tumor progression. Can you arrange for the Avastin infusion? I attached a summary of his MRI pictures here, and a CD is being FedEX to you. Al W.K. Alfred Yung, M.D. Chairman, Department of Neuro-Oncology Margaret and Ben Love Chair in Clinical Cancer Care UT M. D. Anderson Cancer Center, Unit 431 1515 Holcombe Blvd Houston, TX 77030 Tele: 713-794-1285 Fax: 713-563-0151 wyung@mdanderson.org The information contained in this transmission contains privileged and confidential information. It is intended only for the use of the person named above. If you are not the intended recipient, you are hereby notified that any review, dissemination, distribution or duplication of this communication is strictly prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message. CAUTION: Intended recipients should NOT use email communication for emergent or urgent health care matters.
METADATA:
THREAD:
TOPIC:
mutual patient
INDEX:
Ac9YtDOelnUXc70wRVakdMLcgjvGNwABtOd8AAFH94AAAQDU6wAAZKcAAAiNeho=
REFERENCES:
REPLY_TO:
<1397578452218.641cbc4f@Nodemailer>
REFS:
<90455dd8ef5c4a7abcff10c22dced984@BY2PR05MB742.namprd05.prod.outlook.com>,<1397578452218.641cbc4f@Nodemailer>